[Action of a new synthetic ACTH drug in psoriatic arthropathy].

In light of observations in 10 patients the author reports the results of a course of therapy with synthetic depot tetracosactide (SYNACTHEN DEPOT) in psoriatic arthritis. In 2 patients no improvement was evident, while in 3 patients temporary improvement was observed but the effect of the drug was inadequate except in combination. In 5 patients, following intramuscular administration of 1 mg without any other medication, improvement in the symptoms and the objective articular findings, where ankylosis was not present, was observed within a few hours and this improvement lasted for more than one week.